Invivyd (IVVD) Net Cash Flow (QoQ) (2021 - 2025)
Invivyd (IVVD) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Invivyd |
168.41 Mn |
-58.28 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
183.09% |
| Sep 30, 2025 |
479.80% |
| Jun 30, 2025 |
38.01% |
| Mar 31, 2025 |
43.34% |
| Dec 31, 2024 |
8.50% |
| Sep 30, 2024 |
1.19% |
| Jun 30, 2024 |
-268.85% |
| Mar 31, 2024 |
-159.80% |
| Dec 31, 2023 |
-68.57% |
| Sep 30, 2023 |
1,422.91% |
| Jun 30, 2023 |
-113.16% |
| Mar 31, 2023 |
118.49% |
| Dec 31, 2022 |
5.42% |
| Sep 30, 2022 |
-243.13% |
| Jun 30, 2022 |
-473.12% |
| Mar 31, 2022 |
-115.64% |
| Dec 31, 2021 |
-25.43% |
| Sep 30, 2021 |
-71.53% |
| Jun 30, 2021 |
1,368.95% |
